00:00 Can Congressman Chris Jacobs see the future?
00:02 It honestly sure seems like it.
00:04 Back in June, he bought stock in Axum Therapeutics.
00:06 At the time, the stock was trading for around $22 a share.
00:09 Today, Axum's drug that treats depression received FDA approval, leading to a nearly
00:13 40% one-day gain.
00:14 And the stock is now trading for around $60.
00:17 That's more than a 170% return in two months.
00:20 Jacobs sits on the subcommittee for biotechnology, so it's clear he knew there was potential.
00:24 Or maybe he just got lucky.
00:25 Either way, you can check out all legislator trades at QuiverQuant.
00:28 And as always, thanks for watching.
00:30 (dramatic music)
Comments